| Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets Á Nagy, A Lánczky, O Menyhárt, B Győrffy Scientific reports 8 (1), 9227, 2018 | 1235 | 2018 |
| Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma O Menyhárt, Á Nagy, B Győrffy Royal Society open science 5 (12), 181006, 2018 | 361 | 2018 |
| Guidelines for the selection of functional assays to evaluate the hallmarks of cancer O Menyhárt, H Harami-Papp, S Sukumar, R Schäfer, L Magnani, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1866 (2), 300-319, 2016 | 161 | 2016 |
| Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis O Menyhárt, B Győrffy Computational and structural biotechnology journal 19, 949-960, 2021 | 150 | 2021 |
| MultipleTesting. com: A tool for life science researchers for multiple hypothesis testing correction O Menyhart, B Weltz, B Győrffy PloS one 16 (6), e0245824, 2021 | 82 | 2021 |
| HOXC10 expression supports the development of chemotherapy resistance by fine tuning DNA repair in breast cancer cells H Sadik, P Korangath, NK Nguyen, B Gyorffy, R Kumar, M Hedayati, ... Cancer research 76 (15), 4443-4456, 2016 | 73 | 2016 |
| Author Correction: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets Á Nagy, A Lánczky, O Menyhárt, B Győrffy Scientific reports 8, 2018 | 69 | 2018 |
| Juvenile zebra finches learn the underlying structural regularities of their fathers’ song O Menyhart, O Kolodny, MH Goldstein, TJ DeVoogd, S Edelman Frontiers in Psychology 6, 571, 2015 | 65 | 2015 |
| Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches O Menyhárt, B Győrffy Cancer and Metastasis Reviews 39, 211-233, 2020 | 59 | 2020 |
| Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas O Menyhárt, F Giangaspero, B Győrffy Journal of Hematology & Oncology 12, 1-17, 2019 | 58 | 2019 |
| A comprehensive outline of trastuzumab resistance biomarkers in HER2 overexpressing breast cancer O Menyhart, L Santarpia, B Gyorffy Current Cancer Drug Targets 15 (8), 665-683, 2015 | 55 | 2015 |
| Demographic shift disproportionately increases cancer burden in an aging nation: current and expected incidence and mortality in Hungary up to 2030 O Menyhárt, JT Fekete, B Győrffy Clinical Epidemiology, 1093-1108, 2018 | 43 | 2018 |
| Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 2018; 8: 9227 Á Nagy, A Lánczky, O Menyhárt, B Győrffy Journal of Gastrointestinal Oncology. All rights reserved. J Gastrointest …, 2020 | 34 | 2020 |
| Mutations defining patient cohorts with elevated PD-L1 expression in gastric cancer O Menyhárt, LS Pongor, B Győrffy Frontiers in Pharmacology 9, 430580, 2019 | 33 | 2019 |
| DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer O Menyhart, J Budczies, G Munkácsy, FJ Esteva, A Szabó, TP Miquel, ... Oncotarget 8 (44), 77207, 2017 | 33 | 2017 |
| Principles of tumorigenesis and emerging molecular drivers of SHH‐activated medulloblastomas O Menyhárt, B Győrffy Annals of Clinical and Translational Neurology 6 (5), 990-1005, 2019 | 27 | 2019 |
| Contingent parental responses are naturally associated with zebra finch song learning S Carouso-Peck, O Menyhart, TJ DeVoogd, MH Goldstein Animal Behaviour 165, 123-132, 2020 | 24 | 2020 |
| Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies O Menyhárt, JT Fekete, B Győrffy Carcinogenesis 42 (6), 804-813, 2021 | 22 | 2021 |
| Uncovering potential therapeutic targets in colorectal cancer by deciphering mutational status and expression of druggable oncogenes O Menyhart, T Kakisaka, LS Pongor, H Uetake, A Goel, B Győrffy Cancers 11 (7), 983, 2019 | 22 | 2019 |
| Gene expression indicates altered immune modulation and signaling pathway activation in ovarian cancer patients resistant to topotecan O Menyhárt, JT Fekete, B Győrffy International Journal of Molecular Sciences 20 (11), 2750, 2019 | 20 | 2019 |
